TLR7 and cancer: For instance, tumor-derived sEVs enriched in miR-21 have been shown to activate Toll-like receptors 7 and 8 (TLR7/8), inducing proinflammatory cytokines such as IL-6 and TNF-α, and promoting cachexia in murine cancer models [10,177].